Literature DB >> 25099597

Breast-cancer predisposition in multiple endocrine neoplasia type 1.

Koen M A Dreijerink1, Pierre Goudet, John R Burgess, Gerlof D Valk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25099597      PMCID： PMC4243053          DOI： 10.1056/NEJMc1406028

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Authors:  Rajesh V Thakker; Paul J Newey; Gerard V Walls; John Bilezikian; Henning Dralle; Peter R Ebeling; Shlomo Melmed; Akihiro Sakurai; Francesco Tonelli; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

2.  Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients.

Authors:  Joanne M de Laat; Carolina R C Pieterman; Maaike Weijmans; Ad R Hermus; Olaf M Dekkers; Wouter W de Herder; Anouk N A van der Horst-Schrivers; Madeleine L Drent; Peter H Bisschop; Bas Havekes; Menno R Vriens; Gerlof D Valk
Journal:  J Clin Endocrinol Metab       Date:  2013-08-16       Impact factor: 5.958

3.  Menin links estrogen receptor activation to histone H3K4 trimethylation.

Authors:  Koen M A Dreijerink; Klaas W Mulder; G Sebastiaan Winkler; Jo W M Höppener; Cornelis J M Lips; H Th Marc Timmers
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

4.  Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.

Authors:  Hitomi Imachi; Koji Murao; Hiroaki Dobashi; Mohammad M Bhuyan; Xueyuan Cao; Keiichi Kontani; Shoko Niki; Chisa Murazawa; Hiroo Nakajima; Norio Kohno; Hiroko Yamashita; Hirotaka Iwase; Shin-ichi Hayashi; Toshihiko Ishida; Akira Yamauchi
Journal:  Breast Cancer Res Treat       Date:  2009-10-22       Impact factor: 4.872

5.  High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.

Authors:  Christelle Seigne; Magdalena Auret; Isabelle Treilleux; Rémy Bonnavion; Fouzia Assade; Christine Carreira; Sophie Goddard-Léon; Emilie Lavergne; Sylvie Chabaud; Amandine Garcia; Sylvie Mazoyer; Jieli Lu; Thomas Bachelot; Lucien Frappart; Chang Xian Zhang
Journal:  J Pathol       Date:  2013-03       Impact factor: 7.996
  5 in total
  32 in total

1.  The need for national registries for rare endocrine tumor syndromes.

Authors:  Rachel S van Leeuwaarde; Wouter W de Herder; Gerlof D Valk
Journal:  Endocrine       Date:  2017-04-17       Impact factor: 3.633

Review 2.  Clinical aspects of multiple endocrine neoplasia type 1.

Authors:  Abdallah Al-Salameh; Guillaume Cadiot; Alain Calender; Pierre Goudet; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2021-02-09       Impact factor: 43.330

3.  Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.

Authors:  Koen M A Dreijerink; Anna C Groner; Erica S M Vos; Alba Font-Tello; Lei Gu; David Chi; Jaime Reyes; Jennifer Cook; Elgene Lim; Charles Y Lin; Wouter de Laat; Prakash K Rao; Henry W Long; Myles Brown
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

Review 4.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 5.  Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Authors:  Nadine Tung; Susan M Domchek; Zsofia Stadler; Katherine L Nathanson; Fergus Couch; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  Nat Rev Clin Oncol       Date:  2016-06-14       Impact factor: 66.675

Review 6.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

Review 7.  Recent Topics Around Multiple Endocrine Neoplasia Type 1.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

8.  Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.

Authors:  Sarah M Nielsen; Diana M Eccles; Iris L Romero; Fahd Al-Mulla; Judith Balmaña; Michela Biancolella; Rien Bslok; Maria Adelaide Caligo; Mariarosaria Calvello; Gabriele Lorenzo Capone; Pietro Cavalli; T L Chris Chan; Kathleen B M Claes; Laura Cortesi; Fergus J Couch; Miguel de la Hoya; Simona De Toffol; Orland Diez; Susan M Domchek; Ros Eeles; Anna Efremidis; Florentia Fostira; David Goldgar; Andreas Hadjisavvas; Thomas V O Hansen; Akira Hirasawa; Claude Houdayer; Petra Kleiblova; Sophie Krieger; Conxi Lázaro; Maria Loizidou; Siranoush Manoukian; Arjen R Mensenkamp; Setareh Moghadasi; Alvaro N Monteiro; Luigi Mori; April Morrow; Nadia Naldi; Henriette R Nielsen; Olufunmilayo I Olopade; Nicholas S Pachter; Edenir I Palmero; Inge S Pedersen; Maria Piane; Marianna Puzzo; Mark Robson; Maria Rossing; Maria Christina Sini; Angela Solano; Jana Soukupova; Gianluca Tedaldi; Manuel Teixeira; Mads Thomassen; Maria Grazia Tibiletti; Amanda Toland; Therese Törngren; Erica Vaccari; Liliana Varesco; Ana Vega; Yvonne Wallis; Barbara Wappenschmidt; Jeffrey Weitzel; Amanda B Spurdle; Arcangela De Nicolo; Encarna B Gómez-García
Journal:  JCO Precis Oncol       Date:  2018-10-26

Review 9.  Gender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening?

Authors:  Jerena Manoharan; Carmen Bollmann; Peter Herbert Kann; Pietro Di Fazio; Detlef K Bartsch; Max B Albers
Journal:  Visc Med       Date:  2020-01-24

Review 10.  Current and emerging therapies for PNETs in patients with or without MEN1.

Authors:  Morten Frost; Kate E Lines; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2018-02-16       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.